Taysha Gene Therapies Inc (TSHA)
R&D Expenses
$122.56M
TTM · Period ending: · USD
TSHA R&D Expenses
Latest reported$122.56Mperiod ending
Latest reported$122.56Mperiod ending
TSHA R&D Expenses ($987.00K → $122.56M)
Annual R&D Expenses
High-resolution chart · PNG
TSHA r&d expenses history
Annual fiscal periods · USD. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | R&D Expenses (USD) |
|---|---|
| 86,403,000 | |
| 66,001,000 | |
| 56,778,000 | |
| 91,169,000 | |
| 131,943,000 | |
| 31,893,000 | |
| 987,000 |